Identifying Risks for Early Onset Pre-Eclampsia | Zendy

Morey Kraus | Zendy; K. H. Nicolaides | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Identifying Risks for Early Onset Pre-Eclampsia

Author(s) -

Morey Kraus,

K. H. Nicolaides

Publication year - 2015

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/whe.14.72

Subject(s) - eclampsia , medicine , pregnancy , biology , genetics

2015 Morey Kraus has served as Chief Scientific Officer of the Diagnostics division of PerkinElmer, Inc. since 2007. He is the scientific founder of ViaCord, PerkinElmer’s family cord blood and tissue preservation business. Prior to his work at ViaCord, he was the founder, chairman and chief executive officer of t. Breeders, a cellular therapy company focused on stem cell expansion technologies for clinical transplantation. Morey was a PhD candidate at Worcester Polytechnic Institute in an interdisciplinary Bioprocess Engineering Program combining Chemical Engineering and Biotechnology. Morey has published numerous articles in various peer-reviewed journals on topics ranging from the expansion of umbilical cord blood stem cells for clinical use to the in vivo homing of uncultured and selectively amplified cord blood stem cells. In addition, he is the inventor or co-inventor on numerous issued patents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research